Physician profile
Robert G Mitchell
NPI 1750399564
$22,762.13
in general payments reported to CMS, 2019-2025
18 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $934 · 2020: $12K · 2021: $5,517 · 2022: $1,813 · 2023: $1,661 · 2024: $191 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $644.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20,441.96 | 2019-2023 | Lifevest |
| Biotronik INC. | $1,681.60 | 2019-2025 | Biomonitor, Pamira, Amvia Edge |
| Janssen Pharmaceuticals, INC | $128.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $116.09 | 2019-2025 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $58.80 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $48.84 | 2019 | |
| Mylan Specialty L.P. | $48.23 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $38.37 | 2019 | |
| Amgen INC. | $35.58 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $33.96 | 2019-2020 | |
| Boston Scientific Corporation | $27.52 | 2025 | Watchman Flx |
| Chiesi USA, INC. | $18.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.99 | 2019 | |
| United Therapeutics Corporation | $15.44 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.85 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aegerion Pharmaceuticals, INC. | $13.92 | 2019 | |
| Medtronic Vascular, INC. | $13.13 | 2019 | |
| Mallinckrodt Enterprises LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.